ANETUMAB
UNII WVL0274BWW

Substance Identification & Data

This profile provides standardized clinical and technical data for Anetumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WVL0274BWW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1954758-84-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WVL0274BWW
CAS Registry Number
1954758-84-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ANETUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anetumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ANETUMAB
IMMUNOGLOBULIN G1, ANTI-(HUMAN MESOTHELIN) (HUMAN MONOCLONAL MF-T-IGG1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MF-T-IGG1 .LAMBDA.-CHAIN, DIMER

Technical Codes

AGC-2400
BAY 86-1903
BAY-86-1903